Abstract:Clinical significance of combined detection of CCL22 and IL‐1 as potential new bronchial inflammatory mediators in children asthma. Backgrounds Severe asthma is a significant health burden because children with severe asthma are vulnerable to medication‐related side effects, life‐threatening deterioration, and impaired quality of life. However, there is a lack of data to elucidate the role of inflammatory variables in asthma. This study aimed to compare the levels of inflammatory factors in serum and sputum in children with acute and stable asthma to those in healthy children and the ability to predict clinical response to azithromycin therapy. Methods This study recruited 95 individuals aged 1−3 years old and collected data from January 2018 to 2020. We examined serum and sputum inflammatory factors and constructed the least absolute shrinkage and selection operator (LASSO) model. Predictive models were constructed through multifactor logistic regression and presented in the form of column‐line plots. The performance of the column‐line diagrams was measured by subject work characteristics (ROC) curves, calibration plots, and decision curve analysis (DCA). Then, filter‐paper samples were collected from 45 children with acute asthma who were randomly assigned to receive either azithromycin (10 mg/kg, n = 22) or placebo (n = 23). Pretreatment levels of immune mediators were then analyzed and compared with clinical response to azithromycin therapy. Results Of the 95 eligible participants, 21 (22.11%) were healthy controls, 29 (30.53%) had stable asthma, and 45 (47.37%) had acute asthma. The levels of interferon‐γ (IFN‐γ), tumor necrosis factor‐a (TNF‐α), chemokine CCL22 (CCL22), interleukin 12 (IL‐12), chemokine CCL4 (CCL4), chemokine CCL2 (CCL2), and chemokine CCL13 (CCL13)were significantly higher in the acute asthma group than in the stable asthma group. A logistic regression analysis was performed using CCL22 and IL‐1 as independent variables. Additionally, IFN‐γ, TNF‐α, IL‐1, IL‐13, and CCL22 were identified in the LASSO model. Finally, we found that CCL22 and IL‐1 were more responsive in predicting the response to azithromycin treatment. Conclusion Our results show that CCL22 and IL‐1 are both representative markers during asthma symptom exacerbations and an immune mediator that can predict response to azithromycin therapy.

Expression and clinical significance of OX40 and sOX40L in asthma patients

SOX40L: an important inflammatory mediator in adult bronchial asthma.

The upregulated expression of OX40/OX40L and their promotion of T cells proliferation in the murine model of asthma.

Crucial Role of OX40/OX40L Signaling in a Murine Model of Asthma.

Correlation investigation of signal molecule CD40/CD40L and children asthma

OX40L Induces Helper T Cell Differentiation During Cell Immunity of Asthma Through PI3K/AKT and P38 MAPK Signaling Pathway.

The Peripheral Blood Expression of Platelet-Derived CD40L,CD62P and Its Clinical Significance in Asthma

Increases in peripheral SIRT1: A new biological characteristic of asthma.

Expression of Heme Oxygenase-1 in the Peripheral Blood Mononuclear Cells from Asthmatic Patients

An observation of plasma of interleukin-5 and interleukin-10 concentrations in asthmatic patients

The expression of CD40 and CD40L on the surface of peripheral blood mononuclear cells in asthmatic rats and the effect of antiCD40L McAb on Th1 and Th2 cytokines

Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)

CD4+ CD25+ regulatory T cells and expressions of forkhead/winged helix transcription factor ( Foxp 3 ) mRNA in peripheral blood of patients with asthma

[Expressions and Clinical Significance of OX40 and OX40L in Peripheral Blood of Patients with Primary Sjogren's Syndrome].

Expression of 4-1BBL in the Peripheral Blood from Patients with Allergic Bronchial Asthma

Serum Souluble CD86 Levels in Asthmatic Patients and the Effects of Inhalation

Expression and Significance of CD4~+CD25~+T Lymphocyte in Patient with Asthma

Clinical Significance of Combined Detection of CCL22 and IL‐1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma

Expressions of CD4~+CD_(45)RA and CD4~+CD_(45)RO in Peripheral Blood CD4~+T Lymphocytes in Children with Bronchial Asthma

A Comparison of Serum and Sputum Inflammatory Mediator Profiles in Patients with Asthma and COPD.

Study the inflammatory cells expressing of TGF-β1 in sputum of children asthma